Showing results (441-450 of 1,398) with videos related to
Sort By:
Pageof 140
Drug Development Research|November 11, 2014
Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature reviewMaria Sole Chimenti, Francesca Romana Spinelli, Alessandro Giunta, et al.Drug Development Research|November 11, 2014
Pharmacogenetics and future therapeutic scenarios: what affects the prediction of response to treatment with etanercept?Giuseppe Murdaca, Rossella Gulli, Francesca Spanò, et al.Drug Development Research|November 11, 2014
Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical responseFabio Cacciapaglia, Maria Grazia Anelli, Angela Rinaldi, et al.Drug Development Research|November 11, 2014
Cardiovascular risk in psoriatic patients detected by heart rate variability (HRV) analysisIlaria Proietti, Gianfranco Raimondi, Nevena Skroza, et al.Drug Development Research|October 16, 2014
Visualization of plasma and tissue binding using dose fractions parameterAndreas SvennebringDrug Development Research|October 16, 2014
Comparison of antidepressant-like and abuse-related effects of phencyclidine in ratsTodd M Hillhouse, Joseph H Porter, S Stevens NegusDrug Development Research|November 20, 2014
Inhibition of LPS-induced TLR4 signaling products in murine macrophages by phenylmethimazole: an assay methodology for screening potential phenylmethimazole analogsSudhir P Deosarkar, Pooja Bhatt, Jessica Gillespie, et al.Drug Development Research|January 17, 2020
Novel 3-aryl-5-substituted-coumarin analogues: Synthesis and bioactivity profileEleni Kavetsou, Annita Katopodi, Letta Argyri, et al.Drug Development Research|September 8, 2020
New multitarget directed benzimidazole-2-thiol-based heterocycles as prospective anti-radical and anti-Alzheimer's agentsAbdul Latif, Samina Bibi, Sardar Ali, et al.Drug Development Research|November 2, 2020
"Azole" as privileged heterocycle for targeting the inducible cyclooxygenase enzymeParteek Prasher, Mousmee SharmaPageof 140